Specialties
Cartilage Repair
Specialties
Hip
Specialties
Regenerative Medicine
286 results found in 5ms
Cartilage specialist or general orthopaedic surgeon for a knee defectCartilage specialist or general orthopaedic surgeon for a knee defect
Knee cartilage repair without correcting underlying malalignment results in reoperation in 47.4% of cases, versus 17.3% when alignment is corrected simultaneously — a surgical integration that general orthopaedic surgeons often omit from initial assessment and planning.Knee cartilage repair without correcting underlying malalignment results in reoperation in 47.4% of cases, versus 17.3% when alignment is corrected simultaneously — a surgical integration that general orthopaedic surgeons often omit from initial assessment and planning.
ChondroFiller injection for talar osteochondral lesionsChondroFiller injection for talar osteochondral lesions
An ultrasound-guided collagen scaffold injected in clinic, ChondroFiller recruits the patient's own progenitor cells to repair focal cartilage defects on the talar dome that persist despite at least six months of conservative care.An ultrasound-guided collagen scaffold injected in clinic, ChondroFiller recruits the patient's own progenitor cells to repair focal cartilage defects on the talar dome that persist despite at least six months of conservative care.
Choosing between ACI and MACI for cartilage repairChoosing between ACI and MACI for cartilage repair
MACI cartilage grafts show 90% fill at two years but decline to 49% by ten years; 73% become fibrocartilage rather than the hyaline cartilage needed for durability.MACI cartilage grafts show 90% fill at two years but decline to 49% by ten years; 73% become fibrocartilage rather than the hyaline cartilage needed for durability.
ChondroFiller injection versus cartilage surgeryChondroFiller injection versus cartilage surgery
ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.
What separates ChondroFiller from Liquid CartilageWhat separates ChondroFiller from Liquid Cartilage
ChondroFiller is a single collagen scaffold delivered two ways: as an outpatient injection alone, or combined with patient-derived cells under the clinical brand Liquid Cartilage™. Naming overlap at clinics obscures which is being offered.ChondroFiller is a single collagen scaffold delivered two ways: as an outpatient injection alone, or combined with patient-derived cells under the clinical brand Liquid Cartilage™. Naming overlap at clinics obscures which is being offered.
ChondroFiller injection safety and the questions to askChondroFiller injection safety and the questions to ask
ChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.ChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.
MACI recovery and return to sportMACI recovery and return to sport
MACI recovery takes twelve to eighteen months before high-impact sport. Most patients return to some sport, but only one-third reach their pre-injury level — a gap significantly driven by kinesiophobia, which clinical teams can screen and address through sports psychology support.MACI recovery takes twelve to eighteen months before high-impact sport. Most patients return to some sport, but only one-third reach their pre-injury level — a gap significantly driven by kinesiophobia, which clinical teams can screen and address through sports psychology support.
ChondroFiller versus hyaluronic acid for cartilage defectsChondroFiller versus hyaluronic acid for cartilage defects
ChondroFiller fills discrete cartilage defects using a cell-recruiting scaffold; hyaluronic acid treats diffuse osteoarthritis through joint lubrication. They address different pathologies, and the choice depends on imaging, not on how much pain a patient experiences.ChondroFiller fills discrete cartilage defects using a cell-recruiting scaffold; hyaluronic acid treats diffuse osteoarthritis through joint lubrication. They address different pathologies, and the choice depends on imaging, not on how much pain a patient experiences.
When cartilage repair is the right choiceWhen cartilage repair is the right choice
Cartilage repair is only for younger, active patients with small focal defects who can sustain nine to eighteen months of intensive rehabilitation.Cartilage repair is only for younger, active patients with small focal defects who can sustain nine to eighteen months of intensive rehabilitation.
ChondroFiller NHS status and private access routesChondroFiller NHS status and private access routes
ChondroFiller is not available on the NHS, pending formal health technology assessment; private, self-funded treatment is the sole current UK access route.ChondroFiller is not available on the NHS, pending formal health technology assessment; private, self-funded treatment is the sole current UK access route.
OATS versus osteochondral allograft for large knee defectsOATS versus osteochondral allograft for large knee defects
Defect size determines which procedure: OATS, harvesting cartilage plugs from the patient's own knee, suits lesions up to 4 cm²; osteochondral allograft, using donor tissue, handles larger defects without an equivalent size limit.Defect size determines which procedure: OATS, harvesting cartilage plugs from the patient's own knee, suits lesions up to 4 cm²; osteochondral allograft, using donor tissue, handles larger defects without an equivalent size limit.
ChondroFiller for TMJ cartilage defectsChondroFiller for TMJ cartilage defects
ChondroFiller, an injectable collagen scaffold that recruits cartilage-forming cells, shows functional improvements in small-joint cartilage structurally similar to the TMJ, but remains an emerging, untested application for the jaw.ChondroFiller, an injectable collagen scaffold that recruits cartilage-forming cells, shows functional improvements in small-joint cartilage structurally similar to the TMJ, but remains an emerging, untested application for the jaw.
286 results found in 5ms